HRG petition on Zelnorm
Executive Summary
FDA responded to Public Citizen Health Research Group's petition not to approve Novartis' irritable bowel syndrome therapy Zelnorm (tegaserod) on Nov. 6. "As Novartis announced in a press release dated June 18, 2001, FDA recently refused to approve Zelnorm," FDA noted. "Therefore, your petition is granted"...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.